Within the secondary analysis, the much less conservative but clinically meaningful criterion of stable response (described to be a fifty% or more reduction in MADRS from baseline for 2 weeks) was used. Of your patients who attained secure response, twenty five.eight% within the esketamine group and fifty seven.6% during the https://friedrichg555crg2.blogvivi.com/profile